clindamycin has been researched along with Drug Abuse, Intravenous in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ilyas, AM; Kistler, JM; Thoder, JJ | 1 |
Rueegg, CA; Scholtze, D | 1 |
Gaughan, J; Ilyas, AM; Tosti, R; Trionfo, A | 1 |
Abbott, IJ; Spelman, D | 1 |
Cui, X; Eichacker, PQ; Hicks, CW; Li, Y; Sweeney, DA | 1 |
Naique, S; Patel, NK; Windley, J | 1 |
Abdlslam, K; Gibson, RJ; Thumbikat, P | 1 |
Cohen, SH; Flynn, NM; Huang, H; King, JH; Monchaud, C; Morita, M | 1 |
2 review(s) available for clindamycin and Drug Abuse, Intravenous
Article | Year |
---|---|
MRSA Incidence and Antibiotic Trends in Urban Hand Infections: A 10-Year Longitudinal Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bites and Stings; Clindamycin; Coinfection; Drug Resistance, Bacterial; Female; Hand; Humans; Incidence; Levofloxacin; Longitudinal Studies; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Substance Abuse, Intravenous; Wounds and Injuries; Young Adult | 2019 |
An overview of anthrax infection including the recently identified form of disease in injection drug users.
Topics: Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxacin; Clindamycin; Doxycycline; Humans; Penicillins; Substance Abuse, Intravenous | 2012 |
6 other study(ies) available for clindamycin and Drug Abuse, Intravenous
Article | Year |
---|---|
Pulmonary talc granulomatosis mimicking lung cancer.
Topics: Central Nervous System Stimulants; Clindamycin; Diagnosis, Differential; Granuloma, Foreign-Body; Humans; Lung; Lung Diseases; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Substance Abuse, Intravenous; Substance-Related Disorders; Talc; Treatment Outcome | 2019 |
Risk factors associated with clindamycin-resistant, methicillin-resistant Staphylococcus aureus in hand abscesses.
Topics: Abscess; Age Factors; Anti-Bacterial Agents; Clindamycin; Cross Infection; Drug Resistance, Multiple, Bacterial; Hand; Humans; Methicillin-Resistant Staphylococcus aureus; Multivariate Analysis; Risk Factors; Staphylococcal Infections; Substance Abuse, Intravenous | 2015 |
Bacteriology and management of necrotizing soft tissue infections.
Topics: Clindamycin; Clostridium botulinum; Clostridium Infections; Clostridium perfringens; Clostridium sordellii; Clostridium tetani; Community-Acquired Infections; Emergency Service, Hospital; Fasciitis, Necrotizing; Humans; Immunoglobulins, Intravenous; Radiography; Soft Tissue Infections; Substance Abuse, Intravenous | 2009 |
Atraumatic posterior dislocation of the native hip: an unusual presentation of septic arthritis.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Arthroplasty; Ceftriaxone; Clindamycin; Debridement; Floxacillin; Heroin Dependence; Hip Dislocation; Hip Joint; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Osteomyelitis; Radiography; Staphylococcal Infections; Substance Abuse, Intravenous | 2014 |
Anaerobic infection of the lumbar spine in an intravenous drug abuser.
Topics: Adult; Anaerobiosis; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Epidural Abscess; Female; Humans; Metronidazole; Spine; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous | 2002 |
Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; California; Clindamycin; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Female; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous | 2006 |